ArticleBMC cancer2025

Pretreatment plasma sCD14 as a prognostic indicator in advanced non-small cell lung cancer patients undergoing immunotherapy.

Liyuan Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.